首页 > 最新文献

Scandinavian Journal of Surgery最新文献

英文 中文
Laparoscopic cholecystectomy versus antibiotic therapy for acute cholecystitis in patients over 75 years: Randomized clinical trial and retrospective cohort study. 腹腔镜胆囊切除术与抗生素治疗75岁以上急性胆囊炎患者:随机临床试验和回顾性队列研究
IF 2.4 3区 医学 Q1 SURGERY Pub Date : 2023-12-01 Epub Date: 2023-08-12 DOI: 10.1177/14574969231178650
Antti Kivivuori, Paulina Salminen, Mika Ukkonen, Imre Ilves, Hanna Vihervaara, Kristina Zalevskaja, Jenni Pajari, Hannu Paajanen, Tuomo Rantanen

Background and objective: The prevalence of acute cholecystitis among elderly patients is increasing. The aim of this study was to compare laparoscopic cholecystectomy (LC) to antibiotics in elderly patients with acute cholecystitis.

Methods: A randomized multicenter clinical trial including patients over 75 years with acute calculous cholecystitis was conducted in four hospitals in Finland between January 2017 and December 2019. Patients were randomized to undergo LC or antibiotic therapy. Due to patient enrollment challenges, the trial was prematurely terminated in December 2019. To assess all eligible patients, we performed a retrospective cohort study including all patients over 75 years with acute cholecystitis during the study period. The primary outcome was morbidity. Predefined secondary outcomes included mortality, readmission rate, and length of hospital stay.

Results: Among 42 randomized patients (LC n = 24, antibiotics n = 18, mean age 82 years, 43% women), the complication rate was 17% (n = 4/24) after cholecystectomy and 33% (n = 6/18, 5/6 patients underwent cholecystectomy due to antibiotic treatment failure) after antibiotics (p = 0.209). In the retrospective cohort (n = 630, mean age 83 years, 49% women), 37% (236/630) of the patients were treated with cholecystectomy and 63% (394/630) with antibiotics. Readmissions were less common after surgical treatment compared with antibiotics in both randomized and retrospective cohort patients (8% vs 44%, p < 0.001% and 11 vs 32%, p < 0.001, respectively). There was no 30-day mortality within the randomized trial. In the retrospective patient cohort, overall mortality was 6% (35/630).

Conclusions: LC may be superior to antibiotic therapy for acute cholecystitis in the selected group of elderly patients with acute cholecystitis.

背景与目的:急性胆囊炎在老年患者中的发病率呈上升趋势。本研究的目的是比较腹腔镜胆囊切除术(LC)与抗生素治疗老年急性胆囊炎患者。方法:2017年1月至2019年12月,在芬兰4家医院对75岁以上急性结石性胆囊炎患者进行随机多中心临床试验。患者随机接受LC或抗生素治疗。由于患者登记方面的挑战,该试验于2019年12月提前终止。为了评估所有符合条件的患者,我们进行了一项回顾性队列研究,包括研究期间所有75岁以上急性胆囊炎患者。主要结局是发病率。预先确定的次要结局包括死亡率、再入院率和住院时间。结果:42例随机患者(LC 24例,抗生素18例,平均年龄82岁,女性43%),术后并发症发生率为17% (n = 4/24),术后并发症发生率为33% (n = 6/18, 5/6患者因抗生素治疗失败而行胆囊切除术)(p = 0.209)。在回顾性队列中(n = 630,平均年龄83岁,49%为女性),37%(236/630)的患者接受胆囊切除术治疗,63%(394/630)的患者接受抗生素治疗。与随机和回顾性队列患者相比,手术治疗后再入院的患者较少(8% vs 44%, p)。结论:在选定的老年急性胆囊炎患者组中,LC可能优于抗生素治疗急性胆囊炎。
{"title":"Laparoscopic cholecystectomy versus antibiotic therapy for acute cholecystitis in patients over 75 years: Randomized clinical trial and retrospective cohort study.","authors":"Antti Kivivuori, Paulina Salminen, Mika Ukkonen, Imre Ilves, Hanna Vihervaara, Kristina Zalevskaja, Jenni Pajari, Hannu Paajanen, Tuomo Rantanen","doi":"10.1177/14574969231178650","DOIUrl":"10.1177/14574969231178650","url":null,"abstract":"<p><strong>Background and objective: </strong>The prevalence of acute cholecystitis among elderly patients is increasing. The aim of this study was to compare laparoscopic cholecystectomy (LC) to antibiotics in elderly patients with acute cholecystitis.</p><p><strong>Methods: </strong>A randomized multicenter clinical trial including patients over 75 years with acute calculous cholecystitis was conducted in four hospitals in Finland between January 2017 and December 2019. Patients were randomized to undergo LC or antibiotic therapy. Due to patient enrollment challenges, the trial was prematurely terminated in December 2019. To assess all eligible patients, we performed a retrospective cohort study including all patients over 75 years with acute cholecystitis during the study period. The primary outcome was morbidity. Predefined secondary outcomes included mortality, readmission rate, and length of hospital stay.</p><p><strong>Results: </strong>Among 42 randomized patients (LC n = 24, antibiotics n = 18, mean age 82 years, 43% women), the complication rate was 17% (n = 4/24) after cholecystectomy and 33% (n = 6/18, 5/6 patients underwent cholecystectomy due to antibiotic treatment failure) after antibiotics (p = 0.209). In the retrospective cohort (n = 630, mean age 83 years, 49% women), 37% (236/630) of the patients were treated with cholecystectomy and 63% (394/630) with antibiotics. Readmissions were less common after surgical treatment compared with antibiotics in both randomized and retrospective cohort patients (8% vs 44%, p < 0.001% and 11 vs 32%, p < 0.001, respectively). There was no 30-day mortality within the randomized trial. In the retrospective patient cohort, overall mortality was 6% (35/630).</p><p><strong>Conclusions: </strong>LC may be superior to antibiotic therapy for acute cholecystitis in the selected group of elderly patients with acute cholecystitis.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":" ","pages":"219-226"},"PeriodicalIF":2.4,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10334841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late cancelations in plastic and reconstructive surgery: A departmental study. 整形外科和重建外科的晚期取消:一项部门研究。
IF 2.4 3区 医学 Q1 SURGERY Pub Date : 2023-12-01 Epub Date: 2023-09-27 DOI: 10.1177/14574969231201791
Liisa Hänninen-Khoda, Virve Koljonen, Tuija Ylä-Kotola
(
{"title":"Late cancelations in plastic and reconstructive surgery: A departmental study.","authors":"Liisa Hänninen-Khoda, Virve Koljonen, Tuija Ylä-Kotola","doi":"10.1177/14574969231201791","DOIUrl":"10.1177/14574969231201791","url":null,"abstract":"(","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":" ","pages":"269-271"},"PeriodicalIF":2.4,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41118165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of and adherence to an ERAS® and prehabilitation protocol for patients undergoing pancreatic surgery: An observational study. 胰腺手术患者ERAS®和康复方案的制定和遵守:一项观察性研究。
IF 2.4 3区 医学 Q1 SURGERY Pub Date : 2023-12-01 Epub Date: 2023-07-18 DOI: 10.1177/14574969231186274
Monika Fagevik Olsén, Thomas Andersson, Micheline Al Nouh, Erik Johnson, Linda Block, My Vakk, Johanna Wennerblom

Background and objective: There are still gaps in knowledge concerning the adherence to different multimodal pathways in pancreatic surgery. The aim of this trial was to explore and evaluate an Enhanced Recovery After Surgery (ERAS®) and prehabilitation protocol in patients undergoing open pancreatic surgery.

Methods: Three groups of patients were included: two prospective series of 75 patients undergoing open pancreatic surgery following an ERAS® protocol with or without prehabilitation, and one group of 55 historical controls. Variables regarding adherence to, and effects of the protocols, were collected from the local database and the patients' hospital records. Patients' adherence to advice given pre-operatively was followed up using a study-specific questionnaire.

Results: The patients reported high adherence to remembered advice given. The health care professionals' adherence to the various parts of the concepts varied. ERAS® implementation resulted in more frequent gut motility stimulation (p < 0.001) and shorter duration of epidural anesthesia, site drains, and urinary catheter (p = 0.001). With prehabilitation, more patients were screened concerning nutritional status and prescribed preoperative training (p < 001). There was a significant change in weight before surgery, a shorter time to first flatus and a shorter length of stay after implementation of the concepts (p < 0.05). Complications were rare in all three groups and there were no significant differences between the groups.

Conclusion: The implementation of an ERAS® and a prehabilitation protocol increased adherence to the protocols by both patients and healthcare professionals. An implementation of an ERAS® protocol with and without prehabilitation decreases length of stay and may decrease preoperative weight loss and time to bowel movement.

背景与目的:关于胰腺手术中不同多模式通路的依从性,目前仍存在知识空白。本试验的目的是探索和评估胰开放性手术患者的术后增强恢复(ERAS®)和康复方案。方法:包括三组患者:两个前瞻性系列,75名患者接受开放胰腺手术,遵循ERAS®方案,有或没有预康复,一组55名历史对照组。从当地数据库和患者的医院记录中收集了有关遵守协议和协议效果的变量。患者对术前建议的依从性采用研究专用问卷进行随访。结果:患者对所给予的建议有较高的依从性。卫生保健专业人员对概念各部分的坚持程度各不相同。ERAS®的实施导致更频繁的肠道运动刺激(p p = 0.001)。在康复过程中,更多的患者接受了营养状况和术前培训的筛查(p p)。结论:ERAS®和康复方案的实施增加了患者和医疗保健专业人员对方案的依从性。ERAS®方案的实施,无论是否进行康复治疗,都可以缩短住院时间,并可能减少术前体重减轻和排便时间。
{"title":"Development of and adherence to an ERAS<sup>®</sup> and prehabilitation protocol for patients undergoing pancreatic surgery: An observational study.","authors":"Monika Fagevik Olsén, Thomas Andersson, Micheline Al Nouh, Erik Johnson, Linda Block, My Vakk, Johanna Wennerblom","doi":"10.1177/14574969231186274","DOIUrl":"10.1177/14574969231186274","url":null,"abstract":"<p><strong>Background and objective: </strong>There are still gaps in knowledge concerning the adherence to different multimodal pathways in pancreatic surgery. The aim of this trial was to explore and evaluate an Enhanced Recovery After Surgery (ERAS<sup>®</sup>) and prehabilitation protocol in patients undergoing open pancreatic surgery.</p><p><strong>Methods: </strong>Three groups of patients were included: two prospective series of 75 patients undergoing open pancreatic surgery following an ERAS<sup>®</sup> protocol with or without prehabilitation, and one group of 55 historical controls. Variables regarding adherence to, and effects of the protocols, were collected from the local database and the patients' hospital records. Patients' adherence to advice given pre-operatively was followed up using a study-specific questionnaire.</p><p><strong>Results: </strong>The patients reported high adherence to remembered advice given. The health care professionals' adherence to the various parts of the concepts varied. ERAS<sup>®</sup> implementation resulted in more frequent gut motility stimulation (<i>p</i> < 0.001) and shorter duration of epidural anesthesia, site drains, and urinary catheter (<i>p</i> = 0.001). With prehabilitation, more patients were screened concerning nutritional status and prescribed preoperative training (<i>p</i> < 001). There was a significant change in weight before surgery, a shorter time to first flatus and a shorter length of stay after implementation of the concepts (<i>p</i> < 0.05). Complications were rare in all three groups and there were no significant differences between the groups.</p><p><strong>Conclusion: </strong>The implementation of an ERAS<sup>®</sup> and a prehabilitation protocol increased adherence to the protocols by both patients and healthcare professionals. An implementation of an ERAS<sup>®</sup> protocol with and without prehabilitation decreases length of stay and may decrease preoperative weight loss and time to bowel movement.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":" ","pages":"235-245"},"PeriodicalIF":2.4,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10185842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Splenic flexure mobilization and anastomotic leakage in anterior resection for rectal cancer: A multicentre cohort study. 直肠癌前切除术中脾脏屈曲活动和吻合口漏:一项多中心队列研究。
IF 2.4 3区 医学 Q1 SURGERY Pub Date : 2023-12-01 Epub Date: 2023-09-07 DOI: 10.1177/14574969231181222
Martin Rutegård, Johan Svensson, Josefin Segelman, Peter Matthiessen, Marie-Louise Lydrup, Jennifer Park

Background and objective: Some colorectal surgeons advocate routine splenic flexure mobilization (SFM) when performing anterior resection for rectal cancer to ensure a tension-free anastomosis. Meta-analyses of smaller studies suggest that this approach does not influence anastomotic leakage rates, but larger multicentre studies are needed to confirm the safety of a selective strategy. The aim of this study is to evaluate the impact of SFM on anastomotic leakage.

Methods: This is a retrospective multicentre cohort study, comprising 1109 patients operated with anterior resection for rectal cancer in 2014-2018. Exposure was SFM, while anastomotic leakage within a year constituted the outcome. Stratified analyses were performed for type of mesorectal excision and surgical approach, as well as sensitivity analysis considering vascular tie placement. Multivariable Cox regression with hazard ratios (HRs) and 95% confidence intervals (CIs) was employed to adjust for confounding, while multiple imputation was used for missing data.

Results: SFM was performed in 381 patients (34.4%). Anastomotic leakage occurred in 83 (21.8%) and 123 (20.3%) patients operated with and without SFM, respectively. SFM was neither clearly detrimental nor beneficial regarding anastomotic leakage (adjusted HR = 0.82; 95% CI: 0.59-1.15), with no apparent differences for total or partial mesorectal excision and minimally invasive or open surgery. Concurrent high vascular ligation did not impact these results, and there was no evidence of interaction from centers with a more common use of SFM.

Conclusions: SFM did not seem to influence the risk of anastomotic leakage after anterior resection for rectal cancer, regardless of type of mesorectal excision, use of minimally invasive surgery, or high vascular ligation.

背景与目的:一些结直肠外科医生在直肠癌前切除术时提倡常规脾屈曲动员(SFM),以确保无张力吻合。小型研究的荟萃分析表明,这种方法不影响吻合口漏率,但需要更大规模的多中心研究来证实这种选择性策略的安全性。本研究的目的是评估SFM对吻合口瘘的影响。方法:这是一项回顾性多中心队列研究,包括2014-2018年1109例直肠癌前切除术患者。术后1年内吻合口瘘,术后1年内吻合口瘘。对直肠系膜切除类型和手术入路进行分层分析,并考虑血管结放置的敏感性分析。采用风险比(hr)和95%置信区间(ci)的多变量Cox回归来调整混杂因素,而对缺失数据采用多重插值。结果:381例(34.4%)患者行SFM手术。吻合口瘘发生率分别为83例(21.8%)和123例(20.3%)。对于吻合口瘘,SFM既无明显的有害作用,也无明显的益处(调整后HR = 0.82;95% CI: 0.59-1.15),完全或部分肠系膜切除与微创或开放手术无明显差异。同时高位血管结扎对这些结果没有影响,也没有证据表明SFM更常用的中心存在相互作用。结论:无论直肠系膜切除方式、微创手术或高位血管结扎方式,SFM似乎都不会影响直肠癌前切除术后吻合口漏的风险。
{"title":"Splenic flexure mobilization and anastomotic leakage in anterior resection for rectal cancer: A multicentre cohort study.","authors":"Martin Rutegård, Johan Svensson, Josefin Segelman, Peter Matthiessen, Marie-Louise Lydrup, Jennifer Park","doi":"10.1177/14574969231181222","DOIUrl":"10.1177/14574969231181222","url":null,"abstract":"<p><strong>Background and objective: </strong>Some colorectal surgeons advocate routine splenic flexure mobilization (SFM) when performing anterior resection for rectal cancer to ensure a tension-free anastomosis. Meta-analyses of smaller studies suggest that this approach does not influence anastomotic leakage rates, but larger multicentre studies are needed to confirm the safety of a selective strategy. The aim of this study is to evaluate the impact of SFM on anastomotic leakage.</p><p><strong>Methods: </strong>This is a retrospective multicentre cohort study, comprising 1109 patients operated with anterior resection for rectal cancer in 2014-2018. Exposure was SFM, while anastomotic leakage within a year constituted the outcome. Stratified analyses were performed for type of mesorectal excision and surgical approach, as well as sensitivity analysis considering vascular tie placement. Multivariable Cox regression with hazard ratios (HRs) and 95% confidence intervals (CIs) was employed to adjust for confounding, while multiple imputation was used for missing data.</p><p><strong>Results: </strong>SFM was performed in 381 patients (34.4%). Anastomotic leakage occurred in 83 (21.8%) and 123 (20.3%) patients operated with and without SFM, respectively. SFM was neither clearly detrimental nor beneficial regarding anastomotic leakage (adjusted HR = 0.82; 95% CI: 0.59-1.15), with no apparent differences for total or partial mesorectal excision and minimally invasive or open surgery. Concurrent high vascular ligation did not impact these results, and there was no evidence of interaction from centers with a more common use of SFM.</p><p><strong>Conclusions: </strong>SFM did not seem to influence the risk of anastomotic leakage after anterior resection for rectal cancer, regardless of type of mesorectal excision, use of minimally invasive surgery, or high vascular ligation.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":" ","pages":"246-255"},"PeriodicalIF":2.4,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10607818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome following soft tissue coverage with a medial gastrocnemius flap of an exposed or infected total knee arthroplasty. 暴露或感染的全膝关节置换术后用腓肠肌内侧皮瓣覆盖软组织的结果。
IF 2.4 3区 医学 Q1 SURGERY Pub Date : 2023-09-01 DOI: 10.1177/14574969231175562
Rebecca Wiberg, Camilla Mukka, Olof Backman, Göran Stålhult, David Edmundsson, Sebastian Mukka

Background: Soft tissue defects or periprosthetic infections after total knee arthroplasty (TKA) are severe complications that may lead to loss of the arthroplasty or the limb. Reconstructions with medial gastrocnemius flaps (MGF) are occasionally used to provide soft tissue coverage around the knee.

Aims: The study aimed to establish the rate of implant survivorship after MGF reconstruction for soft tissue coverage in the treatment of exposed or infected TKA and to establish functional outcome.

Methods: A retrospective analysis was performed on all patients who received soft tissue coverage with an MGF of an exposed or infected TKA between 2000 and 2017 at the Department of Hand and Plastic Surgery at Umeå University Hospital. The outcomes were implant survivorship and patient-reported outcome measures (PROMs) using the five-level EQ-5D version and The Knee Injury and Osteoarthritis Outcome Score.

Results: Forty-seven patients (mean age = 67 years, 30 women) were included. The mean time between flap coverage and follow-up was 6.7 (±3.4) years. Implant survivorship was observed in 28 of 47 (59.6%) patients at follow-up. Flap failure was rare, with only 3 of 47 (6.4%) cases. Of the 20 patients who answered the PROMs, 10 of 20 experienced moderate to severe pain or discomfort.

Conclusions: Due to unfavorable underlying conditions, MGF reconstruction after TKA is often associated with a compromised functional outcome. Because donor site morbidity is limited and flap failure is unusual, the procedure can be considered prophylactically in a small subset of patients with risk factors to prevent soft tissue defects and periprosthetic joint infection.

背景:全膝关节置换术(TKA)后软组织缺损或假体周围感染是严重的并发症,可能导致置换术或肢体的丧失。内侧腓肠肌皮瓣(MGF)重建偶尔用于提供膝关节周围的软组织覆盖。目的:本研究旨在确定MGF重建软组织覆盖治疗暴露或感染TKA后的种植体成活率,并确定功能结局。方法:回顾性分析2000年至2017年在尤梅夫大学医院手整形外科接受暴露或感染TKA的MGF软组织覆盖的所有患者。结果是使用5级EQ-5D版本和膝关节损伤和骨关节炎结局评分的植入物存活率和患者报告的结果测量(PROMs)。结果:纳入47例患者(平均年龄67岁,女性30例)。皮瓣覆盖至随访的平均时间为6.7(±3.4)年。在随访中,47例患者中有28例(59.6%)种植体存活。皮瓣失败很少见,47例中仅有3例(6.4%)。在回答问题的20名患者中,20人中有10人经历了中度到重度的疼痛或不适。结论:由于不利的基础条件,TKA后MGF重建通常与功能预后受损相关。由于供区发病率有限且皮瓣失败不常见,因此在一小部分有危险因素的患者中,可以考虑预防性地进行该手术,以防止软组织缺损和假体周围关节感染。
{"title":"Outcome following soft tissue coverage with a medial gastrocnemius flap of an exposed or infected total knee arthroplasty.","authors":"Rebecca Wiberg,&nbsp;Camilla Mukka,&nbsp;Olof Backman,&nbsp;Göran Stålhult,&nbsp;David Edmundsson,&nbsp;Sebastian Mukka","doi":"10.1177/14574969231175562","DOIUrl":"https://doi.org/10.1177/14574969231175562","url":null,"abstract":"<p><strong>Background: </strong>Soft tissue defects or periprosthetic infections after total knee arthroplasty (TKA) are severe complications that may lead to loss of the arthroplasty or the limb. Reconstructions with medial gastrocnemius flaps (MGF) are occasionally used to provide soft tissue coverage around the knee.</p><p><strong>Aims: </strong>The study aimed to establish the rate of implant survivorship after MGF reconstruction for soft tissue coverage in the treatment of exposed or infected TKA and to establish functional outcome.</p><p><strong>Methods: </strong>A retrospective analysis was performed on all patients who received soft tissue coverage with an MGF of an exposed or infected TKA between 2000 and 2017 at the Department of Hand and Plastic Surgery at Umeå University Hospital. The outcomes were implant survivorship and patient-reported outcome measures (PROMs) using the five-level EQ-5D version and The Knee Injury and Osteoarthritis Outcome Score.</p><p><strong>Results: </strong>Forty-seven patients (mean age = 67 years, 30 women) were included. The mean time between flap coverage and follow-up was 6.7 (±3.4) years. Implant survivorship was observed in 28 of 47 (59.6%) patients at follow-up. Flap failure was rare, with only 3 of 47 (6.4%) cases. Of the 20 patients who answered the PROMs, 10 of 20 experienced moderate to severe pain or discomfort.</p><p><strong>Conclusions: </strong>Due to unfavorable underlying conditions, MGF reconstruction after TKA is often associated with a compromised functional outcome. Because donor site morbidity is limited and flap failure is unusual, the procedure can be considered prophylactically in a small subset of patients with risk factors to prevent soft tissue defects and periprosthetic joint infection.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":"112 3","pages":"173-179"},"PeriodicalIF":2.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10473410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of the BODY-Q Chest module in Finnish trans men undergoing chest wall masculinization. 芬兰跨性别男性胸壁男性化的BODY-Q胸模验证
IF 2.4 3区 医学 Q1 SURGERY Pub Date : 2023-09-01 DOI: 10.1177/14574969231176111
Mirjam Saarinen, Kaisu Ojala, Sinikka Suominen, Jussi Repo

Background and objective: The aim of gender affirmation surgery is to ease gender dysphoria. In transgender men, chest wall masculinization is the most common gender affirmation surgery. The BODY-Q Chest module is currently the only instrument developed to measure health-related quality of life (HRQL) in men undergoing chest wall surgery. Linguistic validation and cultural adaption to Finnish were performed previously. The study aims to validate the BODY-Q Chest module in transgender men who have undergone surgical chest wall masculinization.

Methods: All transgender patients who underwent chest wall masculinization at Helsinki University Hospital between 2005 and 2018 were invited to the study. The BODY-Q Chest module comprises two scales-chest and nipple. Data were obtained using the BODY-Q Chest module, the 15D questionnaire, and specifically targeted items designed by the authors. The statistical analyses were conducted to exclude selection bias, evaluate validity of the instrument, and compare it to other instruments.

Results: Of the 220 patients invited, 123 participated in the survey (response rate 56%). Ceiling effects were observed with 18.9% and 20.5% scoring maximum points. Cronbach's alpha was 0.92 and 0.88 for the chest and nipple scales, respectively. In exploratory factor analysis, both scales loaded to one factor confirming unidimensionality. Correlation with the generic 15D questionnaire was low.

Conclusions: The BODY-Q Chest module provides valid scores with sufficient consistency and reliability when measuring HRQL in transgender men undergoing chest wall masculinization. Moreover, it offers specificity that existing or generic instruments cannot provide. Ceiling effect was expected due to the postoperative status of participants.

背景与目的:性别确认手术的目的是缓解性别焦虑。在跨性别男性中,胸壁男性化是最常见的性别确认手术。BODY-Q胸部模块是目前唯一用于测量接受胸壁手术的男性健康相关生活质量(HRQL)的仪器。先前进行了语言验证和芬兰语的文化适应。该研究旨在验证BODY-Q胸部模块在接受胸壁男性化手术的跨性别男性中的有效性。方法:邀请2005年至2018年间在赫尔辛基大学医院接受胸壁男性化治疗的所有跨性别患者参与研究。BODY-Q胸部模块包括胸部和乳头两个刻度。数据采用BODY-Q Chest模块、15D问卷和作者设计的特定目标项目获得。进行统计分析以排除选择偏倚,评估工具的有效性,并将其与其他工具进行比较。结果:在被邀请的220例患者中,123例参与了调查,有效率56%。天花板效应分别为18.9%和20.5%。胸部和乳头尺度的Cronbach’s alpha分别为0.92和0.88。在探索性因子分析中,两个量表加载到一个因子,确认了单维性。与通用15D问卷的相关性较低。结论:BODY-Q胸部模块在测量接受胸壁男性化的跨性别男性的HRQL时提供了有效的评分,具有足够的一致性和可靠性。此外,它提供了现有或一般文书无法提供的专一性。由于参与者术后的状态,预计会出现天花板效应。
{"title":"Validation of the BODY-Q Chest module in Finnish trans men undergoing chest wall masculinization.","authors":"Mirjam Saarinen,&nbsp;Kaisu Ojala,&nbsp;Sinikka Suominen,&nbsp;Jussi Repo","doi":"10.1177/14574969231176111","DOIUrl":"https://doi.org/10.1177/14574969231176111","url":null,"abstract":"<p><strong>Background and objective: </strong>The aim of gender affirmation surgery is to ease gender dysphoria. In transgender men, chest wall masculinization is the most common gender affirmation surgery. The BODY-Q Chest module is currently the only instrument developed to measure health-related quality of life (HRQL) in men undergoing chest wall surgery. Linguistic validation and cultural adaption to Finnish were performed previously. The study aims to validate the BODY-Q Chest module in transgender men who have undergone surgical chest wall masculinization.</p><p><strong>Methods: </strong>All transgender patients who underwent chest wall masculinization at Helsinki University Hospital between 2005 and 2018 were invited to the study. The BODY-Q Chest module comprises two scales-chest and nipple. Data were obtained using the BODY-Q Chest module, the 15D questionnaire, and specifically targeted items designed by the authors. The statistical analyses were conducted to exclude selection bias, evaluate validity of the instrument, and compare it to other instruments.</p><p><strong>Results: </strong>Of the 220 patients invited, 123 participated in the survey (response rate 56%). Ceiling effects were observed with 18.9% and 20.5% scoring maximum points. Cronbach's alpha was 0.92 and 0.88 for the chest and nipple scales, respectively. In exploratory factor analysis, both scales loaded to one factor confirming unidimensionality. Correlation with the generic 15D questionnaire was low.</p><p><strong>Conclusions: </strong>The BODY-Q Chest module provides valid scores with sufficient consistency and reliability when measuring HRQL in transgender men undergoing chest wall masculinization. Moreover, it offers specificity that existing or generic instruments cannot provide. Ceiling effect was expected due to the postoperative status of participants.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":"112 3","pages":"180-186"},"PeriodicalIF":2.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10473413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk for colorectal cancer after computed tomography verified acute diverticulitis: A retrospective cohort study with long-term follow-up. 计算机断层扫描证实急性憩室炎后结直肠癌的风险:一项长期随访的回顾性队列研究。
IF 2.4 3区 医学 Q1 SURGERY Pub Date : 2023-09-01 DOI: 10.1177/14574969231175567
Leena-Mari Mäntymäki, Juha Grönroos, Markus Riskumäki, Tero Vahlberg, Jukka Karvonen

Background and objective: Colorectal cancer (CRC) can mimic acute diverticulitis and can thus be misdiagnosed. Therefore, colonic evaluation is recommended after an episode of acute diverticulitis. The aim of this study was to analyze the risk of CRC after computed tomography (CT) verified uncomplicated and complicated acute diverticulitis in short-term and, particularly, long-term follow-up to ensure the feasibility of the primary CT imaging in separating patients with uncomplicated and complicated acute diverticulitis.

Methods: A retrospective cohort study was conducted in patients with CT-verified acute diverticulitis in 2003-2012. Data on CT findings and colonic evaluations were analyzed. The patients were divided into those with uncomplicated and complicated acute diverticulitis. Patient charts were reviewed 9-18 years after the initial acute diverticulitis episode.

Results: The study population consisted of 270 patients. According to CT scans, 170 (63%) patients had uncomplicated acute diverticulitis and 100 (37%) had complicated acute diverticulitis. Further colonic evaluation was made in 146 (54%) patients. In the whole study population, CRC was found in 7 (2.6%) patients, but CRC was associated with acute diverticulitis in only 4 (1.5%) patients. The short-term risk for CRC was 0.6% (1/170) in uncomplicated acute diverticulitis and 3.0% (3/100) in complicated acute diverticulitis. No additional CRC was found in patients with complicated acute diverticulitis during the long-term follow-up and three cases of CRC found after uncomplicated acute diverticulitis had no observable association with previous diverticulitis.

Conclusions: In short-term follow-up, the risk of underlying CRC is very low in CT-verified uncomplicated acute diverticulitis but increased in complicated acute diverticulitis. Long-term follow-up revealed no additional CRCs associated with previous acute diverticulitis, indicating that the short-term results remain consistent also in the long run. These long-term results confirm that colonoscopy should be reserved for patients with complicated acute diverticulitis or with persisting or alarming symptoms.

背景与目的:结直肠癌(CRC)可与急性憩室炎相似,因而容易误诊。因此,建议急性憩室炎发作后进行结肠检查。本研究的目的是分析CT证实的急性憩室炎患者在短期特别是长期随访后发生结直肠癌的风险,以确保CT初步成像在区分急性憩室炎患者和非并发症患者中的可行性。方法:对2003-2012年ct证实的急性憩室炎患者进行回顾性队列研究。分析CT表现及结肠评估资料。将患者分为单纯急性憩室炎组和并发急性憩室炎组。在初次急性憩室炎发作后9-18年回顾患者病历。结果:研究人群包括270例患者。CT扫描显示,170例(63%)患者无并发急性憩室炎,100例(37%)患者有并发急性憩室炎。146例(54%)患者进行了进一步的结肠评估。在整个研究人群中,有7例(2.6%)患者发现结直肠癌,但只有4例(1.5%)患者发现结直肠癌与急性憩室炎相关。非并发症急性憩室炎短期发生结直肠癌的风险为0.6%(1/170),并发症急性憩室炎短期发生结直肠癌的风险为3.0%(3/100)。在长期随访中,合并急性憩室炎患者未发现额外的结直肠癌,3例非合并急性憩室炎后发现的结直肠癌与既往憩室炎无明显关联。结论:在短期随访中,ct证实的非并发症急性憩室炎发生CRC的风险很低,而并发症急性憩室炎发生CRC的风险增加。长期随访未发现与既往急性憩室炎相关的额外crc,表明短期结果在长期也保持一致。这些长期结果证实结肠镜检查应保留给并发急性憩室炎或持续或警示症状的患者。
{"title":"Risk for colorectal cancer after computed tomography verified acute diverticulitis: A retrospective cohort study with long-term follow-up.","authors":"Leena-Mari Mäntymäki,&nbsp;Juha Grönroos,&nbsp;Markus Riskumäki,&nbsp;Tero Vahlberg,&nbsp;Jukka Karvonen","doi":"10.1177/14574969231175567","DOIUrl":"https://doi.org/10.1177/14574969231175567","url":null,"abstract":"<p><strong>Background and objective: </strong>Colorectal cancer (CRC) can mimic acute diverticulitis and can thus be misdiagnosed. Therefore, colonic evaluation is recommended after an episode of acute diverticulitis. The aim of this study was to analyze the risk of CRC after computed tomography (CT) verified uncomplicated and complicated acute diverticulitis in short-term and, particularly, long-term follow-up to ensure the feasibility of the primary CT imaging in separating patients with uncomplicated and complicated acute diverticulitis.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted in patients with CT-verified acute diverticulitis in 2003-2012. Data on CT findings and colonic evaluations were analyzed. The patients were divided into those with uncomplicated and complicated acute diverticulitis. Patient charts were reviewed 9-18 years after the initial acute diverticulitis episode.</p><p><strong>Results: </strong>The study population consisted of 270 patients. According to CT scans, 170 (63%) patients had uncomplicated acute diverticulitis and 100 (37%) had complicated acute diverticulitis. Further colonic evaluation was made in 146 (54%) patients. In the whole study population, CRC was found in 7 (2.6%) patients, but CRC was associated with acute diverticulitis in only 4 (1.5%) patients. The short-term risk for CRC was 0.6% (1/170) in uncomplicated acute diverticulitis and 3.0% (3/100) in complicated acute diverticulitis. No additional CRC was found in patients with complicated acute diverticulitis during the long-term follow-up and three cases of CRC found after uncomplicated acute diverticulitis had no observable association with previous diverticulitis.</p><p><strong>Conclusions: </strong>In short-term follow-up, the risk of underlying CRC is very low in CT-verified uncomplicated acute diverticulitis but increased in complicated acute diverticulitis. Long-term follow-up revealed no additional CRCs associated with previous acute diverticulitis, indicating that the short-term results remain consistent also in the long run. These long-term results confirm that colonoscopy should be reserved for patients with complicated acute diverticulitis or with persisting or alarming symptoms.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":"112 3","pages":"157-163"},"PeriodicalIF":2.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10154847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-obstetric surgery during pregnancy and the effects on maternal and fetal outcomes: A systematic review. 妊娠期非产科手术及其对母胎结局的影响:系统综述。
IF 2.4 3区 医学 Q1 SURGERY Pub Date : 2023-09-01 DOI: 10.1177/14574969231175569
Anna Haataja, Hannu Kokki, Outi Uimari, Merja Kokki

Background and objective: Non-obstetric surgery is fairly common in pregnant women. We performed a systematic review to update data on non-obstetric surgery in pregnant women. The aim of this review was to evaluate the effects of non-obstetric surgery during pregnancy on pregnancy, fetal and maternal outcomes.

Methods: A systematic literature search of MEDLINE and Scopus was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The search span was from January 2000 to November 2022. Thirty-six studies matched the inclusion criteria, and 24 publications were identified through reference mining; 60 studies were included in this review. Outcome measures were miscarriage, stillbirth, preterm birth, low birth weight, low Apgar score, and infant and maternal morbidity and mortality rates.

Results: We obtained data for 80,205 women who underwent non-obstetric surgery and data for 16,655,486 women who did not undergo surgery during pregnancy. Prevalence of non-obstetric surgery was between 0.23% and 0.74% (median 0.37%). Appendectomy was the most common procedure with median prevalence of 0.10%. Near half (43%) of the procedures were performed during the second trimester, 32% during the first trimester, and 25% during the third trimester. Half of surgeries were scheduled, and half were emergent. Laparoscopic and open techniques were used equally for abdominal cavity. Women who underwent non-obstetric surgery during pregnancy had increased rate of stillbirth (odds ratio (OR) 2.0) and preterm birth (OR 2.1) compared to women without surgery. Surgery during pregnancy did not increase rate of miscarriage (OR 1.1), low 5 min Apgar scores (OR 1.1), the fetus being small for gestational age (OR 1.1) or congenital anomalies (OR 1.0).

Conclusions: The prevalence of non-obstetric surgery has decreased during last decades, but still two out of 1000 pregnant women have scheduled surgery during pregnancy. Surgery during pregnancy increases the risk of stillbirth, and preterm birth. For abdominal cavity surgery, both laparoscopic and open approaches are feasible.

背景和目的:非产科手术在孕妇中相当普遍。我们对孕妇非产科手术的最新数据进行了系统回顾。本综述的目的是评估妊娠期非产科手术对妊娠、胎儿和产妇结局的影响。方法:按照系统评价和meta分析的首选报告项目指南,在MEDLINE和Scopus中进行系统文献检索。搜索时间从2000年1月到2022年11月。36篇研究符合纳入标准,通过文献挖掘确定了24篇出版物;本综述纳入了60项研究。结局指标包括流产、死产、早产、低出生体重、低阿普加评分、婴儿和孕产妇发病率和死亡率。结果:我们获得了80,205名接受非产科手术的妇女和16,655,486名在怀孕期间未接受手术的妇女的数据。非产科手术的患病率在0.23% ~ 0.74%之间(中位数0.37%)。阑尾切除术是最常见的手术,中位患病率为0.10%。近一半(43%)的手术在妊娠中期进行,32%在妊娠早期进行,25%在妊娠晚期进行。一半的手术是预定的,一半是紧急手术。腹腔镜和开放技术在腹腔同样适用。与未接受手术的妇女相比,在怀孕期间接受非产科手术的妇女死产率(比值比(OR) 2.0)和早产率(OR 2.1)增加。妊娠期手术不增加流产率(OR 1.1)、低5分钟Apgar评分(OR 1.1)、胎儿小于胎龄(OR 1.1)或先天性异常(OR 1.0)。结论:近几十年来,非产科手术的患病率有所下降,但仍有千分之二的孕妇在怀孕期间安排了手术。妊娠期手术会增加死产和早产的风险。对于腹腔手术,腹腔镜和开放两种方法都是可行的。
{"title":"Non-obstetric surgery during pregnancy and the effects on maternal and fetal outcomes: A systematic review.","authors":"Anna Haataja,&nbsp;Hannu Kokki,&nbsp;Outi Uimari,&nbsp;Merja Kokki","doi":"10.1177/14574969231175569","DOIUrl":"https://doi.org/10.1177/14574969231175569","url":null,"abstract":"<p><strong>Background and objective: </strong>Non-obstetric surgery is fairly common in pregnant women. We performed a systematic review to update data on non-obstetric surgery in pregnant women. The aim of this review was to evaluate the effects of non-obstetric surgery during pregnancy on pregnancy, fetal and maternal outcomes.</p><p><strong>Methods: </strong>A systematic literature search of MEDLINE and Scopus was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The search span was from January 2000 to November 2022. Thirty-six studies matched the inclusion criteria, and 24 publications were identified through reference mining; 60 studies were included in this review. Outcome measures were miscarriage, stillbirth, preterm birth, low birth weight, low Apgar score, and infant and maternal morbidity and mortality rates.</p><p><strong>Results: </strong>We obtained data for 80,205 women who underwent non-obstetric surgery and data for 16,655,486 women who did not undergo surgery during pregnancy. Prevalence of non-obstetric surgery was between 0.23% and 0.74% (median 0.37%). Appendectomy was the most common procedure with median prevalence of 0.10%. Near half (43%) of the procedures were performed during the second trimester, 32% during the first trimester, and 25% during the third trimester. Half of surgeries were scheduled, and half were emergent. Laparoscopic and open techniques were used equally for abdominal cavity. Women who underwent non-obstetric surgery during pregnancy had increased rate of stillbirth (odds ratio (OR) 2.0) and preterm birth (OR 2.1) compared to women without surgery. Surgery during pregnancy did not increase rate of miscarriage (OR 1.1), low 5 min Apgar scores (OR 1.1), the fetus being small for gestational age (OR 1.1) or congenital anomalies (OR 1.0).</p><p><strong>Conclusions: </strong>The prevalence of non-obstetric surgery has decreased during last decades, but still two out of 1000 pregnant women have scheduled surgery during pregnancy. Surgery during pregnancy increases the risk of stillbirth, and preterm birth. For abdominal cavity surgery, both laparoscopic and open approaches are feasible.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":"112 3","pages":"187-205"},"PeriodicalIF":2.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10097708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practice patterns in diagnostics, staging, and management strategies of gallbladder cancer among Nordic tertiary centers. 北欧三级中心胆囊癌诊断、分期和治疗策略的实践模式。
IF 2.4 3区 医学 Q1 SURGERY Pub Date : 2023-09-01 DOI: 10.1177/14574969231181228
Sini Takala, Kristoffer Lassen, Kjetil Søreide, Ernesto Sparrelid, Jon-Helge Angelsen, Erling A Bringeland, Malin S Eilard, Oskar Hemmingsson, Bengt Isaksson, Heikki Karjula, Jukka-Pekka Lammi, Peter N Larsen, Maija Lavonius, Gert Lindell, Frank V Mortensen, Kim Mortensen, Arno Nordin, Torsten Pless, Per Sandström, Oddvar Sandvik, Yrjö Vaalavuo, Christina Villard, Ville Sallinen

Background and objective: Gallbladder cancer (GBC) is a rare malignancy in the Nordic countries and no common Nordic treatment guidelines exist. This study aimed to characterize the current diagnostic and treatment strategies in the Nordic countries and disclose differences in these strategies.

Methods: This was a survey study with a cross-sectional questionnaire of all 19 university hospitals providing curative-intent surgery for GBC in Sweden, Norway, Denmark, and Finland.

Results: In all Nordic countries except Sweden, neoadjuvant/downstaging chemotherapy was used in GBC patients. In T1b and T2, majority of the centers (15-18/19) performed extended cholecystectomy. In T3, majority of the centers (13/19) performed cholecystectomy with resection of segments 4b and 5. In T4, majority of the centers (12-14/19) chose palliative/oncological care. The centers in Sweden extended lymphadenectomy beyond the hepatoduodenal ligament, whereas all other Nordic centers usually limited lymphadenectomy to the hepatoduodenal ligament. All Nordic centers except those in Norway used adjuvant chemotherapy routinely for GBC. There were no major differences between the Nordic centers in diagnostics and follow-up.

Conclusions: The surgical and oncological treatment strategies of GBC vary considerably between the Nordic centers and countries.

背景和目的:胆囊癌(GBC)在北欧国家是一种罕见的恶性肿瘤,没有统一的北欧治疗指南。本研究旨在描述北欧国家目前的诊断和治疗策略,并揭示这些策略的差异。方法:这是一项调查研究,采用横断面问卷调查瑞典、挪威、丹麦和芬兰所有19所大学医院为GBC提供治疗目的手术。结果:在除瑞典外的所有北欧国家,GBC患者均采用新辅助/降期化疗。在T1b和T2中,大多数中心(15-18/19)行扩大胆囊切除术。在T3,大多数中心(13/19)行胆囊切除术,切除4b和5节段。在T4期,大多数中心(12-14/19)选择姑息治疗/肿瘤治疗。瑞典的中心将淋巴结切除术扩展到肝十二指肠韧带以外,而所有其他北欧中心通常将淋巴结切除术限制在肝十二指肠韧带。除挪威外,所有北欧中心常规使用辅助化疗治疗GBC。北欧中心在诊断和随访方面没有重大差异。结论:GBC的手术和肿瘤治疗策略在北欧中心和国家之间差异很大。
{"title":"Practice patterns in diagnostics, staging, and management strategies of gallbladder cancer among Nordic tertiary centers.","authors":"Sini Takala,&nbsp;Kristoffer Lassen,&nbsp;Kjetil Søreide,&nbsp;Ernesto Sparrelid,&nbsp;Jon-Helge Angelsen,&nbsp;Erling A Bringeland,&nbsp;Malin S Eilard,&nbsp;Oskar Hemmingsson,&nbsp;Bengt Isaksson,&nbsp;Heikki Karjula,&nbsp;Jukka-Pekka Lammi,&nbsp;Peter N Larsen,&nbsp;Maija Lavonius,&nbsp;Gert Lindell,&nbsp;Frank V Mortensen,&nbsp;Kim Mortensen,&nbsp;Arno Nordin,&nbsp;Torsten Pless,&nbsp;Per Sandström,&nbsp;Oddvar Sandvik,&nbsp;Yrjö Vaalavuo,&nbsp;Christina Villard,&nbsp;Ville Sallinen","doi":"10.1177/14574969231181228","DOIUrl":"https://doi.org/10.1177/14574969231181228","url":null,"abstract":"<p><strong>Background and objective: </strong>Gallbladder cancer (GBC) is a rare malignancy in the Nordic countries and no common Nordic treatment guidelines exist. This study aimed to characterize the current diagnostic and treatment strategies in the Nordic countries and disclose differences in these strategies.</p><p><strong>Methods: </strong>This was a survey study with a cross-sectional questionnaire of all 19 university hospitals providing curative-intent surgery for GBC in Sweden, Norway, Denmark, and Finland.</p><p><strong>Results: </strong>In all Nordic countries except Sweden, neoadjuvant/downstaging chemotherapy was used in GBC patients. In T1b and T2, majority of the centers (15-18/19) performed extended cholecystectomy. In T3, majority of the centers (13/19) performed cholecystectomy with resection of segments 4b and 5. In T4, majority of the centers (12-14/19) chose palliative/oncological care. The centers in Sweden extended lymphadenectomy beyond the hepatoduodenal ligament, whereas all other Nordic centers usually limited lymphadenectomy to the hepatoduodenal ligament. All Nordic centers except those in Norway used adjuvant chemotherapy routinely for GBC. There were no major differences between the Nordic centers in diagnostics and follow-up.</p><p><strong>Conclusions: </strong>The surgical and oncological treatment strategies of GBC vary considerably between the Nordic centers and countries.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":"112 3","pages":"147-156"},"PeriodicalIF":2.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10098277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pelvic bone sarcomas, prognostic factors, and treatment: A narrative review of the literature. 骨盆骨肉瘤,预后因素和治疗:文献综述。
IF 2.4 3区 医学 Q1 SURGERY Pub Date : 2023-09-01 DOI: 10.1177/14574969231181504
Minna K Laitinen, Michael C Parry, Guy V Morris, Lee M Jeys

Primary sarcomas of bone are rare malignant mesenchymal tumors. The most common bone sarcomas are osteosarcoma, Ewing's sarcoma, and chondrosarcoma. The prognosis has improved over the years, but bone sarcomas are still life-threatening tumors that need a multidisciplinary approach for diagnosis and treatment. Bone sarcomas arising in the pelvis present a unique challenge to orthopedic oncologists due to the absence of natural anatomical barriers, the close proximity of vital neurovascular structures, and the high mechanical demands placed on any pelvic reconstruction following the excision of the tumor. While radiotherapy has an important role especially in Ewing's sarcoma and chemotherapy for both Ewing's sarcoma and osteosarcoma, surgery remains the main choice of treatment for all three entities. While external hemipelvectomy has remained one option, the main aim of surgery is limb salvage. After complete tumor resection, the bone defect needs to be reconstructed. Possibilities to reconstruct the defect include prosthetic or biological reconstruction. The method of reconstruction is dependent on the location of tumor and the surgery required for its removal. The aim of this article is to give an insight into pelvic bone sarcomas, their oncological and surgical outcomes, and the options for treatment based on the authors' experiences.

原发性骨肉瘤是一种罕见的恶性间质肿瘤。最常见的骨肉瘤是骨原性肉瘤、尤文氏肉瘤和软骨肉瘤。多年来,预后有所改善,但骨肉瘤仍然是危及生命的肿瘤,需要多学科的诊断和治疗方法。骨盆骨肉瘤对骨科肿瘤学家来说是一个独特的挑战,因为它缺乏天然的解剖屏障,靠近重要的神经血管结构,并且在切除肿瘤后对任何骨盆重建都有很高的机械要求。虽然放疗在尤文氏肉瘤中起着重要的作用,而化疗在尤文氏肉瘤和骨原性肉瘤中都起着重要的作用,但手术仍然是这三种肿瘤的主要治疗选择。虽然外半骨盆切除术仍然是一种选择,但手术的主要目的是保留肢体。肿瘤完全切除后,需要重建骨缺损。修复缺损的方法包括假体或生物修复。重建的方法取决于肿瘤的位置和切除所需的手术。本文的目的是根据作者的经验,深入了解骨盆骨肉瘤,其肿瘤和手术结果,以及治疗方案。
{"title":"Pelvic bone sarcomas, prognostic factors, and treatment: A narrative review of the literature.","authors":"Minna K Laitinen,&nbsp;Michael C Parry,&nbsp;Guy V Morris,&nbsp;Lee M Jeys","doi":"10.1177/14574969231181504","DOIUrl":"https://doi.org/10.1177/14574969231181504","url":null,"abstract":"<p><p>Primary sarcomas of bone are rare malignant mesenchymal tumors. The most common bone sarcomas are osteosarcoma, Ewing's sarcoma, and chondrosarcoma. The prognosis has improved over the years, but bone sarcomas are still life-threatening tumors that need a multidisciplinary approach for diagnosis and treatment. Bone sarcomas arising in the pelvis present a unique challenge to orthopedic oncologists due to the absence of natural anatomical barriers, the close proximity of vital neurovascular structures, and the high mechanical demands placed on any pelvic reconstruction following the excision of the tumor. While radiotherapy has an important role especially in Ewing's sarcoma and chemotherapy for both Ewing's sarcoma and osteosarcoma, surgery remains the main choice of treatment for all three entities. While external hemipelvectomy has remained one option, the main aim of surgery is limb salvage. After complete tumor resection, the bone defect needs to be reconstructed. Possibilities to reconstruct the defect include prosthetic or biological reconstruction. The method of reconstruction is dependent on the location of tumor and the surgery required for its removal. The aim of this article is to give an insight into pelvic bone sarcomas, their oncological and surgical outcomes, and the options for treatment based on the authors' experiences.</p>","PeriodicalId":49566,"journal":{"name":"Scandinavian Journal of Surgery","volume":"112 3","pages":"206-215"},"PeriodicalIF":2.4,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10101961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Scandinavian Journal of Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1